
Applied Nutrition kept its full-year forecasts unchanged after a very strong first quarter, targeting revenue of about £205 million and adjusted EBITDA of around £49 million for the year to July 2027. The company's margin is expected to fall to roughly 24% from 26.8%, largely because of higher whey protein costs and a bigger share of lower-margin US white-label sales.
Whey prices have started to fall, but the company expects its average cost this year to exceed last year's, which squeezes margins for sports nutrition makers that buy whey as an ingredient. Whey is a dairy co-product, so its price moves track the wider dairy complex.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.